Hepatocellular Carcinoma
Antisense nucleotides keep cancer cell proliferation in check
Published in Hepatitis Weekly, November 25th, 2002
Scientists know that hepatoma-derived growth factor energizes the proliferation of liver cancer cells. They suspect that antisense oligonucleotides could be used for blocking hepatoma growth factor expression, which would in turn block cancer growth.
Studies of antisense oligonucleotide to hepatoma-derived growth factor have proven it slows liver cancer cell proliferation in several cell lines, according to Y. Kishima and colleagues, Osaka University Graduate School of Medicine, Osaka, Japan.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-11-25)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Virus activates a protein sometimes linked to onset of cancer - Hepatitis Complications
Combination therapy appropriate for treating hepatitis C-related glomerulopathy - Epidemiology
Routine use of bleach to disinfect syringes may lower odds for hepatitis C - Hepatitis B Virus Vaccine
Postexposure hepatitis B vaccine not effective in hemodialysis patients - Hepatitis C Virus Research
Glucosidase inhibitors could augment interferon in chronic hepatitis C - Blood Safety
First platelet pathogen inactivation system receives CE clearance - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
